Vector Smart Object3
blood cells

Supporting Patients with TDT Learn More About Transfusion-Dependent Beta-Thalassemia (TDT) With These Multimedia Resources

Educational Videos

Hear what beta-thalassemia experts have to say about chronic transfusion and chelation therapy, the benefits and risks associated with HSCT, and the impact of these treatments on patients' quality of life.

Transfusion Therapy Videos

TDT expert Dr. Cappellini discusses transfusion therapy, iron monitoring, chelation, adherence to treatment and her key takeaways.

Hematopoietic Stem Cell Transplantation Videos

HSCT expert Dr. Baronciani discusses the history of HSCT, clinical outcomes in patients with TDT and making the decision to undergo HSCT.

Provider and Patient Resources

Download these resources to learn more about chronic transfusion and chelation therapy, the benefits and risks associated with HSCT, and the impact of these treatments on patients' quality of life.

Provider Resources

Patient Resources

Professional Organizations

Here are some professional organizations with helpful resources and information about beta-thalassemia, transfusion and chelation therapy, allogeneic HSCT, and the impact of TDT on patients' lives.

bluebird bio, Inc. is not responsible for the content provided by third party sites, nor does bluebird bio, Inc. endorse the content of these sites. Above is not a comprehensive list of resources and it is provided for reference only.

bluebird bio, Inc. is not responsible for the content provided by third party sites, nor does bluebird bio, Inc. endorse the content of these sites. Below is not a comprehensive list of resources and it is provided for reference only.

Beta-Thalassemia and TDT

Find information about long-term survival rates of TDT patients treated with hematopoietic stem cell transplantation and analysis stressing the importance of long-term follow-up after hematopoietic stem cell transplantation.

Treatment Guidelines

Find guidelines for the standard monitoring of patients with thalassemia, how chronic transfusion therapy extends life expectancy, and complications of therapy.

Allogeneic HSCT

Learn more about hematopoietic stem cell transplantation in thalassemia, effects on patient quality of life, managing iron overload and sickle cell anemia.

Register now to receive resources to help support your TDT patients, invites to future webinars, and additional information about beta‑thalassemia.

Register for Resources
Share: